M. Kraus & Co’s Medtronic MDT Stock Holding History

M. Kraus & Co’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-36,210	Closed	-$2.92M	–	50
2017 Q1	$2.92M	Sell	36,210 -5,880	-14%	-$459K	1.91%	25
2016 Q4	$3M	Buy	42,090 +5,225	+14%	+$410K	2.05%	25
2016 Q3	$3.19M	Buy	36,865 +4,680	+15%	+$408K	2.2%	25
2016 Q2	$2.79M	Hold	32,185	–	–	1.99%	26
2016 Q1	$2.41M	Sell	32,185 -225	-0.7%	-$16.9K	1.79%	29
2015 Q4	$2.49M	Buy	32,410 +1,190	+4%	+$89.6K	1.87%	27
2015 Q3	$2.09M	Sell	31,220 -245	-0.8%	-$18K	1.68%	31
2015 Q2	$2.33M	Sell	31,465 -6,316	-17%	-$483K	1.69%	29
2015 Q1	$2.95M	Buy	+37,781	New	+$2.86M	2.12%	27
2014 Q4	–	Sell	-38,259	Closed	-$2.37M	–	48
2014 Q3	$2.37M	Sell	38,259 -1,225	-3%	-$77.9K	1.82%	31
2014 Q2	$2.52M	Sell	39,484 -50	-0.1%	-$3.04K	1.91%	32
2014 Q1	$2.43M	Sell	39,534 -20	-0.1%	-$1.17K	1.98%	31
2013 Q4	$2.27M	Buy	+39,554	New	+$2.24M	1.85%	32

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

M. Kraus & Co's MDT Position: Q2 2017 in Review

M. Kraus & Co sold out of Medtronic (MDT) in Q2 2017, closing a stake of 36,210 shares — an estimated $2.92M sold.

M. Kraus & Co first reported a position in MDT in Q4 2013 and held it in 13 quarters. The position peaked at $3.19M in Q3 2016. 1,280 funds tracked by Wall St. Rank hold MDT as of Q2 2017.

M. Kraus & Co reported no remaining Medtronic position as of Q2 2017 after selling out during the quarter.
M. Kraus & Co sold 36,210 Medtronic shares in Q2 2017, an estimated $2.92M.
M. Kraus & Co first reported a position in Medtronic in Q4 2013 and held it in 13 quarters.
M. Kraus & Co's Medtronic position peaked at $3.19M in Q3 2016.
1,280 funds tracked by Wall St. Rank held Medtronic as of Q2 2017.

Based on M. Kraus & Co's 13F filing for Q2 2017, filed 11 Jul 2017.